top of page

Microsite for Innovative Hematology Technology

Background

As the hematology landscape continues to evolve, pharmaceutical and biotech companies face increasing challenges in effectively educating physicians about innovative treatments. Traditional marketing approaches were proving insufficient in fostering meaningful engagement, and there was a growing need for a more targeted and interactive strategy. To address this, the client sought a solution that would leverage expert insights, stimulate discussion among physicians, and create a sustained impact over time.

Target specialties

All global physicians seeking to acquire knowledge about the discussed innovative Hematology technology.

Project description

G-Med hired a steering committee and and created a robust program: Typical industry-standard symposiums runs from a few hours to a couple of days. G-Med created a symposium that ran for an entire year. Each month was dedicated to a different topic with 2 or 3 monthly keynote KOL lectures. Following the KOL lecture, G-Med created interactive sessions including polls, discussion topics, case studies, implementation sessions, peer-to-peer discussions, Q&A's etc. for maximum physician participation and engagement with each other and with the presented material.

Results

Over 42,000 physicians from 92 countries:
• Received daily updates, newsletters, conference highlights and exclusive interviews
• Read, commented and discussed product related abstracts and updates
• Created in-depth threads on the various novel therapy advancements that were presented
• Participated in polls, case studies, and interactive Q&A sessions.

92

Countries

1,000,000

Views

31%

Increase in Active Discussions

bottom of page